Clinical Trials Directory

Trials / Completed

CompletedNCT04811768

Lateral Bony Wall Repositioning in Maxillary Sinus Floor Augmentation

Comparative Clinical and Histological Investigation of Graft Integration Following Piezosurgically Retrieved Lateral Bony Wall Repositioning in Maxillary Sinus Floor Augmentation - Prospective Randomized Controlled Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Semmelweis University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The aim of the present prospective randomized controlled study is to clinically and histologically investigate the safety and efficacy of bony wall repositioning compared to rotary window preparation with membrane coverage in maxillary sinus floor augmentation.

Detailed description

40 patients were randomly divided in two study groups after radiological and clinical evaluation. Both groups received bone grafting by a xenogeneic bone substitute (BSM, cerabone, botiss biomaterials GmbH, Zossen, Germany) using the lateral approach. In the bony wall group (BW), following piezosurgery the retrieved bony wall was repositioned. In the collagen membrane group (CM), the lateral window was created by rotary instruments, covered via a native collagen membrane (collprotect, botiss biomaterials GmbH, Zossen, Germany). After 6 months, biopsies were taken to analyze both approaches in terms of new bone formation. Duration of treatment, the number of perforations, postoperative patient discomfort were registered. Established histopathological analysis and histomorphometrical measurements to analyze the tissue reactions and the tissue distribution, i.e., the fractions of newly formed bone tissue (NB), of remaining bone substitute material (BSM) and connective tissue (CT), were conducted.

Conditions

Interventions

TypeNameDescription
PROCEDUREMaxillary sinus augmentationThe surgery was performed under local anaesthesia in both groups, lateral window preparation and window coverage was carried out based on randomization.

Timeline

Start date
2017-03-01
Primary completion
2018-05-30
Completion
2018-05-30
First posted
2021-03-23
Last updated
2021-03-23

Locations

1 site across 1 country: Hungary

Source: ClinicalTrials.gov record NCT04811768. Inclusion in this directory is not an endorsement.